Cordis plans manufacturing capacity expansion in Ireland:
This article was originally published in Clinica
Executive Summary
Cordis has announced plans to build an 180,000ft2 manufacturing facility and new laboratories in Cashel, Ireland, to support the growing demand for its Cypher family of drug-eluting stents (DES). The facility, expected to be operational in the first half of 2008, will employ over 400 people, and the new labs would create 60 additional positions.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.